LINC02791

Across TCGA pan-cancer cohorts, LINC02791 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC02791 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02791 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02791 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LGG show a favorable association.

STAD, UVM, and ESCA are the cancer types where LINC02791 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.376	0.747	<.001	108	view →
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
ESCA	DFS	Tertile	II,III,IV	0.292	0.541	<.001	72	view →
ACC	OS	Tertile	All	0.146	0.639	.001	36	view →
LIHC	DFS	Tertile	All	0.080	0.553	.004	36	view →
SKCM	DFS	Tertile	All	0.137	0.730	<.001	36	view →
THCA	OS	Tertile	All	0.978	0.990	.016	36	view →
GBM	OS	Tertile	All	0.115	0.415	.008	18	view →
PRAD	OS	Tertile	All	0.816	0.884	.008	12	view →
HNSC	OS	Tertile	III,IV	1.000	0.321	.040	6	view →
LGG	DFS	Tertile	All	1.000	0.813	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC02791–STAD (OS)

Open the STAD breakdown →